Puma Biotechnology (PBYI) Operating Income Growth (5y) (2015 - 2026)
Puma Biotechnology (PBYI) Operating Income Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.27 Bn | 467.47 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.18 Bn | 114.93 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.32 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn |
| 10 | Puma Biotechnology | 409.30 Mn | 371.02 Mn | 34.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.97% |
| Dec 31, 2025 | 28.72% |
| Sep 30, 2025 | 22.77% |
| Jun 30, 2025 | -1.42% |
| Mar 31, 2025 | 17.92% |
| Dec 31, 2024 | 28.78% |
| Sep 30, 2024 | 28.68% |
| Jun 30, 2024 | 38.99% |
| Mar 31, 2024 | -17.43% |
| Dec 31, 2023 | 22.85% |
| Sep 30, 2023 | 22.52% |
| Jun 30, 2023 | 16.19% |
| Mar 31, 2023 | 16.94% |
| Dec 31, 2022 | 16.63% |
| Sep 30, 2022 | 15.22% |
| Jun 30, 2022 | 16.59% |
| Mar 31, 2022 | 60.03% |
| Dec 31, 2021 | 15.93% |
| Sep 30, 2021 | 32.93% |
| Jun 30, 2021 | 24.20% |